BlackRock Group’s Chemours CC Stock Holding History

BlackRock Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9.22M	Buy	417,263 +142,447	+52%	+$2.92M	﹤0.01%	942
2016 Q3	$4.4M	Buy	274,816 +12,268	+5%	+$140K	﹤0.01%	1167
2016 Q2	$2.16M	Sell	262,548 -32,177	-11%	-$287K	﹤0.01%	1514
2016 Q1	$2.06M	Sell	294,725 -221,341	-43%	-$1.11M	﹤0.01%	1525
2015 Q4	$2.77M	Sell	516,066 -514,248	-50%	-$3.29M	﹤0.01%	1321
2015 Q3	$6.67M	Buy	+1,030,314	New	+$10.8M	﹤0.01%	1017

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

BlackRock Group's CC Position: Q4 2016 in Review

BlackRock Group increased its Chemours (CC) stake by 52% in Q4 2016, buying an estimated $2.92M and bringing the position to 417,263 shares worth $9.22M. The position accounts for ﹤0.01% of the portfolio, ranked #942.

BlackRock Group first reported a position in CC in Q3 2015 and has held it in 6 quarters since. 416 funds tracked by Wall St. Rank hold CC as of Q4 2016.

BlackRock Group held 417,263 shares of Chemours worth $9.22M as of Q4 2016.
BlackRock Group bought 142,447 Chemours shares in Q4 2016, an estimated $2.92M.
Chemours made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #942 holding.
BlackRock Group first reported a position in Chemours in Q3 2015 and has held it in 6 quarters since.
416 funds tracked by Wall St. Rank held Chemours as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.